_id
6915f843bc934aba376b256b
Ticker
SHNXY
Name
Shandong Xinhua Pharmaceutical Company Limited
Exchange
PINK
Address
No. 1 Lutai Avenue, Zibo, China, 255086
Country
USA
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Currency
USD
Website
https://www.xhzy.com
Description
Shandong Xinhua Pharmaceutical Company Limited develops, manufactures, and sells bulk pharmaceuticals, preparations, and chemical products in the People's Republic of China, the Americas, Europe, and internationally. It offers antipyretic and analgesic, cardiovascular and cerebrovascular, anti-infective, and central nervous drugs under the Xinhua brand; and contract manufacturing services for active pharmaceutical ingredients and pharmaceutical intermediates, OTC, and generics. The company also provides ibuprofen bulk pharmaceutical products; and prepared Chinese herbal medicine for decoction, traditional Chinese medicine, chemical bulk drugs, chemical preparations, chemical raw materials, antibiotics, biochemical medicines, anesthetics, anti-psychotic drugs, pharmaceutical precursor chemicals, protein assimilation preparations, peptide hormones, medical toxic drugs, etc. In addition, it offers raw materials and intermediates; internet data services, internet sales, and internet information services for pharmaceuticals and medical devices; veterinary drugs and fodders; bulk pharmaceutical and intermediates; steroid system apis and intermediates; and chemical raw materials. Further, the company produces and sells chemical products; exports and imports goods and technologies; and designs medical projects. Additionally, it engages in the property management, nonresidential real estate leasing, and housing leasing activities; certification and import and export business; electrical equipment engineering; installation and testing of chemical equipment; and manufacture of mechanical and electrical equipment, nonstandard equipment, as well as production and hardware and electrical equipment, and electrical installations equipment and manufacture; and sale of controller switching equipment. The company was founded in 1943 and is based in Zibo, the People's Republic of China.
Last Close
18.19
Volume
-
Current Price
18.19
Change
0
Last Updated
2026-01-07T11:43:24.254Z
Image
data:image/webp;base64,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
Ipo Date
-
Market Cap
2000354304
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2025-06-30
Revenue
2208978707.17
Cost Of Revenue
1734975071.74
Gross Profit
474003635.43
Operating Expenses
2029126236.8
Operating Income
179852470.37
Interest Expense
10503868.58
Pretax Income
120837821.5
Net Income
111661273.19
Eps
0.16188035910789572
Dividends Per Share
20552269.66
Shares Outstanding
49477700
Income Tax Expense
-
EBITDA
-
Operating Margin
8.141883386482041
Total Other Income Expense Net
-
Cash
1275011109.26
Short Term Investments
-
Receivables
1095964861.83
Inventories
1228936025.5
Total Current Assets
3992086651
Property Plant Equipment
4241523588.46
Total Assets
9237653787.32
Payables
1321094611.92
Short Term Debt
-
Long Term Debt
490319527.08
Total Liabilities
3872661261.75
Equity
5126743297.32
Bs_currency_symbol
CNY
Depreciation
-
Change In Working Capital
-
Cash From Operations
-
Capital Expenditures
27713248.39
Cash From Investing
-
Cash From Financing
-
Net Change In Cash
-18235500.65
Cf_currency_symbol
CNY
PE
22.7375
PB
2.4473694983341474
ROE
2.1780156858715904
ROA
1.2087622654062988
FCF
-
Fcf Percent
-
Piotroski FScore
2
Health Score
56
Deep Value Investing Score
4.5
Defensive Investing Score
7.5
Dividend Investing Score
2
Economic Moat Investing Score
5.3
Garp Investing Score
2
Growth Investing Score
1.5
Momentum Investing Score
4
Net Net Investing Score
3.5
Quality Investing Score
4.5
Value Investing Score
6.5
Quarters > 0 > quarter
2025-06-30
Quarters > 0 > income Statement > revenue
2208978707.17
Quarters > 0 > income Statement > cost Of Revenue
1734975071.74
Quarters > 0 > income Statement > gross Profit
474003635.43
Quarters > 0 > income Statement > operating Expenses
2029126236.8
Quarters > 0 > income Statement > operating Income
179852470.37
Quarters > 0 > income Statement > interest Expense
10503868.58
Quarters > 0 > income Statement > pretax Income
120837821.5
Quarters > 0 > income Statement > net Income
111661273.19
Quarters > 0 > income Statement > eps
0.16188035910789572
Quarters > 0 > income Statement > dividends Per Share
20552269.66
Quarters > 0 > income Statement > shares Outstanding
689776535
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-
Quarters > 0 > income Statement > operating Margin
8.141883386482041
Quarters > 0 > income Statement > total Other Income Expense Net
-
Quarters > 0 > income Statement > currency_symbol
CNY
Quarters > 0 > balance Sheet > cash
1275011109.26
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
1095964861.83
Quarters > 0 > balance Sheet > inventories
1228936025.5
Quarters > 0 > balance Sheet > total Current Assets
3992086651
Quarters > 0 > balance Sheet > property Plant Equipment
4241523588.46
Quarters > 0 > balance Sheet > total Assets
9237653787.32
Quarters > 0 > balance Sheet > payables
1321094611.92
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
490319527.08
Quarters > 0 > balance Sheet > total Liabilities
3872661261.75
Quarters > 0 > balance Sheet > equity
5126743297.32
Quarters > 0 > balance Sheet > currency_symbol
CNY
Quarters > 0 > cash Flow > net Income
111661273.19
Quarters > 0 > cash Flow > depreciation
-
Quarters > 0 > cash Flow > change In Working Capital
-
Quarters > 0 > cash Flow > cash From Operations
-
Quarters > 0 > cash Flow > capital Expenditures
27713248.39
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
-
Quarters > 0 > cash Flow > net Change In Cash
-18235500.65
Quarters > 0 > cash Flow > currency_symbol
CNY
Quarters > 0 > ratios > PE
0.16188035910789572
Quarters > 0 > ratios > PB
2.4473694983341474
Quarters > 0 > ratios > ROE
2.1780156858715904
Quarters > 0 > ratios > ROA
1.2087622654062988
Quarters > 0 > ratios > FCF
-
Quarters > 0 > ratios > Piotroski FScore
2
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
56
Quarters > 1 > quarter
2025-03-31
Quarters > 1 > income Statement > revenue
2429825335.81
Quarters > 1 > income Statement > cost Of Revenue
1974290313.61
Quarters > 1 > income Statement > gross Profit
455535022.2
Quarters > 1 > income Statement > operating Expenses
2283719479.15
Quarters > 1 > income Statement > operating Income
146105856.66
Quarters > 1 > income Statement > interest Expense
10945223.03
Quarters > 1 > income Statement > pretax Income
142689376.58
Quarters > 1 > income Statement > net Income
112095257.24
Quarters > 1 > income Statement > eps
0.1625095252624098
Quarters > 1 > income Statement > dividends Per Share
767197.22
Quarters > 1 > income Statement > shares Outstanding
689776535
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-
Quarters > 1 > income Statement > operating Margin
6.013018899208018
Quarters > 1 > income Statement > total Other Income Expense Net
-
Quarters > 1 > income Statement > currency_symbol
CNY
Quarters > 1 > balance Sheet > cash
1304573051.73
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
1200307190.06
Quarters > 1 > balance Sheet > inventories
1178376439.76
Quarters > 1 > balance Sheet > total Current Assets
3999396150.59
Quarters > 1 > balance Sheet > property Plant Equipment
4307115416.69
Quarters > 1 > balance Sheet > total Assets
9269855861.11
Quarters > 1 > balance Sheet > payables
1207464541.7
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
398340739.2
Quarters > 1 > balance Sheet > total Liabilities
3879907761.23
Quarters > 1 > balance Sheet > equity
5155519978.65
Quarters > 1 > balance Sheet > currency_symbol
CNY
Quarters > 1 > cash Flow > net Income
112095257.24
Quarters > 1 > cash Flow > depreciation
-
Quarters > 1 > cash Flow > change In Working Capital
-
Quarters > 1 > cash Flow > cash From Operations
-
Quarters > 1 > cash Flow > capital Expenditures
49094672.29
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
-
Quarters > 1 > cash Flow > net Change In Cash
45190754.61
Quarters > 1 > cash Flow > currency_symbol
CNY
Quarters > 1 > ratios > PE
0.1625095252624098
Quarters > 1 > ratios > PB
2.4337089611929907
Quarters > 1 > ratios > ROE
2.1742764591003048
Quarters > 1 > ratios > ROA
1.209244878448168
Quarters > 1 > ratios > FCF
-
Quarters > 1 > ratios > Piotroski FScore
2
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
56
Quarters > 2 > quarter
2024-12-31
Quarters > 2 > income Statement > revenue
1732143562.33
Quarters > 2 > income Statement > cost Of Revenue
1272847345.99
Quarters > 2 > income Statement > gross Profit
459296216.34
Quarters > 2 > income Statement > operating Expenses
1591083027.59
Quarters > 2 > income Statement > operating Income
141060534.74
Quarters > 2 > income Statement > interest Expense
11623616.7
Quarters > 2 > income Statement > pretax Income
140735795.89
Quarters > 2 > income Statement > net Income
125943795.41
Quarters > 2 > income Statement > eps
0.18455801041850886
Quarters > 2 > income Statement > dividends Per Share
11542568
Quarters > 2 > income Statement > shares Outstanding
682407635
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-
Quarters > 2 > income Statement > operating Margin
8.143697659231655
Quarters > 2 > income Statement > total Other Income Expense Net
-
Quarters > 2 > income Statement > currency_symbol
CNY
Quarters > 2 > balance Sheet > cash
1245022873.47
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
868204001.79
Quarters > 2 > balance Sheet > inventories
1272856947.1
Quarters > 2 > balance Sheet > total Current Assets
3726840162.91
Quarters > 2 > balance Sheet > property Plant Equipment
4295643026.55
Quarters > 2 > balance Sheet > total Assets
9019601567.53
Quarters > 2 > balance Sheet > payables
1158679604.12
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
771540739.2
Quarters > 2 > balance Sheet > total Liabilities
3802101150.19
Quarters > 2 > balance Sheet > equity
4991588524.78
Quarters > 2 > balance Sheet > currency_symbol
CNY
Quarters > 2 > cash Flow > net Income
125943795.41
Quarters > 2 > cash Flow > depreciation
-
Quarters > 2 > cash Flow > change In Working Capital
-
Quarters > 2 > cash Flow > cash From Operations
-
Quarters > 2 > cash Flow > capital Expenditures
62734250.08
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
-
Quarters > 2 > cash Flow > net Change In Cash
93889576.07
Quarters > 2 > cash Flow > currency_symbol
CNY
Quarters > 2 > ratios > PE
0.18455801041850886
Quarters > 2 > ratios > PB
2.4867824779681924
Quarters > 2 > ratios > ROE
2.5231205413821822
Quarters > 2 > ratios > ROA
1.3963343554264054
Quarters > 2 > ratios > FCF
-
Quarters > 2 > ratios > Piotroski FScore
2
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
57
Quarters > 3 > quarter
2024-09-30
Quarters > 3 > income Statement > revenue
2001684773.51
Quarters > 3 > income Statement > cost Of Revenue
1603981570.48
Quarters > 3 > income Statement > gross Profit
397703203.03
Quarters > 3 > income Statement > operating Expenses
1901352093.43
Quarters > 3 > income Statement > operating Income
100332680.08
Quarters > 3 > income Statement > interest Expense
10247379.12
Quarters > 3 > income Statement > pretax Income
89553789.74
Quarters > 3 > income Statement > net Income
78675532.99
Quarters > 3 > income Statement > eps
0.1152911089425311
Quarters > 3 > income Statement > dividends Per Share
196720583.31
Quarters > 3 > income Statement > shares Outstanding
682407635
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-
Quarters > 3 > income Statement > operating Margin
5.012411614845046
Quarters > 3 > income Statement > total Other Income Expense Net
-
Quarters > 3 > income Statement > currency_symbol
CNY
Quarters > 3 > balance Sheet > cash
1158318911.44
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
971417192.93
Quarters > 3 > balance Sheet > inventories
1265331335.83
Quarters > 3 > balance Sheet > total Current Assets
3629565392.31
Quarters > 3 > balance Sheet > property Plant Equipment
4220710200.51
Quarters > 3 > balance Sheet > total Assets
8824372920.3
Quarters > 3 > balance Sheet > payables
1106948045.83
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
791040739.2
Quarters > 3 > balance Sheet > total Liabilities
3728365398.25
Quarters > 3 > balance Sheet > equity
4871406971.82
Quarters > 3 > balance Sheet > currency_symbol
CNY
Quarters > 3 > cash Flow > net Income
78675532.99
Quarters > 3 > cash Flow > depreciation
-
Quarters > 3 > cash Flow > change In Working Capital
-
Quarters > 3 > cash Flow > cash From Operations
-
Quarters > 3 > cash Flow > capital Expenditures
52540720.27
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
-
Quarters > 3 > cash Flow > net Change In Cash
192063734.64
Quarters > 3 > cash Flow > currency_symbol
CNY
Quarters > 3 > ratios > PE
0.1152911089425311
Quarters > 3 > ratios > PB
2.548133414526111
Quarters > 3 > ratios > ROE
1.6150474276758309
Quarters > 3 > ratios > ROA
0.8915708084934979
Quarters > 3 > ratios > FCF
-
Quarters > 3 > ratios > Piotroski FScore
2
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
55
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
8466309803.08
Annuals > 0 > income Statement > cost Of Revenue
6424760721.71
Annuals > 0 > income Statement > gross Profit
2041549081.37
Annuals > 0 > income Statement > operating Expenses
7869978606.5
Annuals > 0 > income Statement > operating Income
596331196.58
Annuals > 0 > income Statement > interest Expense
39739279.77
Annuals > 0 > income Statement > pretax Income
533653423.32
Annuals > 0 > income Statement > net Income
470023746.08
Annuals > 0 > income Statement > eps
0.6887726953406669
Annuals > 0 > income Statement > dividends Per Share
225847088.62
Annuals > 0 > income Statement > shares Outstanding
682407635
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-
Annuals > 0 > income Statement > operating Margin
7.043578730878214
Annuals > 0 > income Statement > total Other Income Expense Net
-
Annuals > 0 > income Statement > currency_symbol
CNY
Annuals > 0 > balance Sheet > cash
1245022873.47
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
868204001.79
Annuals > 0 > balance Sheet > inventories
1272856947.1
Annuals > 0 > balance Sheet > total Current Assets
3726840162.91
Annuals > 0 > balance Sheet > property Plant Equipment
4295643026.55
Annuals > 0 > balance Sheet > total Assets
9019601567.53
Annuals > 0 > balance Sheet > payables
1158679604.12
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
771540739.2
Annuals > 0 > balance Sheet > total Liabilities
3802101150.19
Annuals > 0 > balance Sheet > equity
4991588524.78
Annuals > 0 > balance Sheet > currency_symbol
CNY
Annuals > 0 > cash Flow > net Income
470023746.08
Annuals > 0 > cash Flow > depreciation
540945176.17
Annuals > 0 > cash Flow > change In Working Capital
-780251071.01
Annuals > 0 > cash Flow > cash From Operations
367610448.95
Annuals > 0 > cash Flow > capital Expenditures
212421547.59
Annuals > 0 > cash Flow > cash From Investing
-
Annuals > 0 > cash Flow > cash From Financing
-
Annuals > 0 > cash Flow > net Change In Cash
355190755.19
Annuals > 0 > cash Flow > currency_symbol
CNY
Annuals > 0 > ratios > PE
0.6887726953406669
Annuals > 0 > ratios > PB
2.4867824779681924
Annuals > 0 > ratios > ROE
9.416315943244058
Annuals > 0 > ratios > ROA
5.211136462746381
Annuals > 0 > ratios > FCF
155188901.35999998
Annuals > 0 > ratios > Piotroski FScore
3
Annuals > 0 > ratios > fcf Percent
0.018330170401222864
Annuals > 0 > health Score
58
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
8100844707.33
Annuals > 1 > income Statement > cost Of Revenue
5709142351
Annuals > 1 > income Statement > gross Profit
2391702356.33
Annuals > 1 > income Statement > operating Expenses
7488651265.47
Annuals > 1 > income Statement > operating Income
612193441.86
Annuals > 1 > income Statement > interest Expense
41148585.76
Annuals > 1 > income Statement > pretax Income
532685725.02
Annuals > 1 > income Statement > net Income
496512201.25
Annuals > 1 > income Statement > eps
0.7359194209379879
Annuals > 1 > income Statement > dividends Per Share
175904735.71
Annuals > 1 > income Statement > shares Outstanding
674682835
Annuals > 1 > income Statement > income Tax Expense
-
Annuals > 1 > income Statement > EBITDA
-
Annuals > 1 > income Statement > operating Margin
7.557155629783405
Annuals > 1 > income Statement > total Other Income Expense Net
-
Annuals > 1 > income Statement > currency_symbol
CNY
Annuals > 1 > balance Sheet > cash
918334462.29
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
699877948.91
Annuals > 1 > balance Sheet > inventories
1312983676.75
Annuals > 1 > balance Sheet > total Current Assets
3314333616.01
Annuals > 1 > balance Sheet > property Plant Equipment
4060814007.23
Annuals > 1 > balance Sheet > total Assets
8286166330.9
Annuals > 1 > balance Sheet > payables
1177843465.04
Annuals > 1 > balance Sheet > short Term Debt
-
Annuals > 1 > balance Sheet > long Term Debt
799400000
Annuals > 1 > balance Sheet > total Liabilities
3510413044.14
Annuals > 1 > balance Sheet > equity
4553103869.56
Annuals > 1 > balance Sheet > currency_symbol
CNY
Annuals > 1 > cash Flow > net Income
496512200
Annuals > 1 > cash Flow > depreciation
516938057.5
Annuals > 1 > cash Flow > change In Working Capital
-870743070.14
Annuals > 1 > cash Flow > cash From Operations
265278895.87
Annuals > 1 > cash Flow > capital Expenditures
325133303.8
Annuals > 1 > cash Flow > cash From Investing
-
Annuals > 1 > cash Flow > cash From Financing
-
Annuals > 1 > cash Flow > net Change In Cash
-229080092.64
Annuals > 1 > cash Flow > currency_symbol
CNY
Annuals > 1 > ratios > PE
0.7359194209379879
Annuals > 1 > ratios > PB
2.6954097952164617
Annuals > 1 > ratios > ROE
10.904917073591418
Annuals > 1 > ratios > ROA
5.9920617258001805
Annuals > 1 > ratios > FCF
-59854407.93000001
Annuals > 1 > ratios > Piotroski FScore
3
Annuals > 1 > ratios > fcf Percent
-0.007388662552170777
Annuals > 1 > health Score
61
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
7502987102.09
Annuals > 2 > income Statement > cost Of Revenue
5465656107.15
Annuals > 2 > income Statement > gross Profit
2037330994.94
Annuals > 2 > income Statement > operating Expenses
6959563987.7
Annuals > 2 > income Statement > operating Income
543423114.39
Annuals > 2 > income Statement > interest Expense
49706941.36
Annuals > 2 > income Statement > pretax Income
471774350.61
Annuals > 2 > income Statement > net Income
411063056.58
Annuals > 2 > income Statement > eps
0.6138684854716221
Annuals > 2 > income Statement > dividends Per Share
163010059.43
Annuals > 2 > income Statement > shares Outstanding
669627235
Annuals > 2 > income Statement > income Tax Expense
-
Annuals > 2 > income Statement > EBITDA
1006288422.61
Annuals > 2 > income Statement > operating Margin
7.242756877972326
Annuals > 2 > income Statement > total Other Income Expense Net
-
Annuals > 2 > income Statement > currency_symbol
CNY
Annuals > 2 > balance Sheet > cash
1158741565.9
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
761259339.93
Annuals > 2 > balance Sheet > inventories
1211987048.39
Annuals > 2 > balance Sheet > total Current Assets
3456959427.88
Annuals > 2 > balance Sheet > property Plant Equipment
4000465351.25
Annuals > 2 > balance Sheet > total Assets
8264790395.98
Annuals > 2 > balance Sheet > payables
1090080345.14
Annuals > 2 > balance Sheet > short Term Debt
-
Annuals > 2 > balance Sheet > long Term Debt
545655801.48
Annuals > 2 > balance Sheet > total Liabilities
3915226169.32
Annuals > 2 > balance Sheet > equity
4126274379.52
Annuals > 2 > balance Sheet > currency_symbol
CNY
Annuals > 2 > cash Flow > net Income
411193688
Annuals > 2 > cash Flow > depreciation
484807130.64
Annuals > 2 > cash Flow > change In Working Capital
-265187575.1
Annuals > 2 > cash Flow > cash From Operations
758240601.5
Annuals > 2 > cash Flow > capital Expenditures
244757671.36
Annuals > 2 > cash Flow > cash From Investing
-
Annuals > 2 > cash Flow > cash From Financing
-
Annuals > 2 > cash Flow > net Change In Cash
414372758.82
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
0.6138684854716221
Annuals > 2 > ratios > PB
2.951941214841591
Annuals > 2 > ratios > ROE
9.962087315866231
Annuals > 2 > ratios > ROA
4.973665838881303
Annuals > 2 > ratios > FCF
513482930.14
Annuals > 2 > ratios > Piotroski FScore
4
Annuals > 2 > ratios > fcf Percent
0.06843713352472196
Annuals > 2 > health Score
65
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
6560077586.4
Annuals > 3 > income Statement > cost Of Revenue
4786410352.3
Annuals > 3 > income Statement > gross Profit
1773667234.1
Annuals > 3 > income Statement > operating Expenses
6061091204.53
Annuals > 3 > income Statement > operating Income
498986381.87
Annuals > 3 > income Statement > interest Expense
53103372.79
Annuals > 3 > income Statement > pretax Income
421233319.92
Annuals > 3 > income Statement > net Income
348548495.99
Annuals > 3 > income Statement > eps
0.5555731296813684
Annuals > 3 > income Statement > dividends Per Share
148433153.71
Annuals > 3 > income Statement > shares Outstanding
627367447
Annuals > 3 > income Statement > income Tax Expense
-
Annuals > 3 > income Statement > EBITDA
908665209.23
Annuals > 3 > income Statement > operating Margin
7.606409761135627
Annuals > 3 > income Statement > total Other Income Expense Net
-
Annuals > 3 > income Statement > currency_symbol
CNY
Annuals > 3 > balance Sheet > cash
744662302.34
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
658568486.25
Annuals > 3 > balance Sheet > inventories
1027539968.72
Annuals > 3 > balance Sheet > total Current Assets
2753958305.88
Annuals > 3 > balance Sheet > property Plant Equipment
3765724308.3
Annuals > 3 > balance Sheet > total Assets
7332033657.98
Annuals > 3 > balance Sheet > payables
1066391477.21
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
346196870.64
Annuals > 3 > balance Sheet > total Liabilities
3680888823.85
Annuals > 3 > balance Sheet > equity
3467941567.45
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
348548501
Annuals > 3 > cash Flow > depreciation
434328516.52
Annuals > 3 > cash Flow > change In Working Capital
-539556038.85
Annuals > 3 > cash Flow > cash From Operations
259116960.17
Annuals > 3 > cash Flow > capital Expenditures
249227103.62
Annuals > 3 > cash Flow > cash From Investing
-
Annuals > 3 > cash Flow > cash From Financing
-
Annuals > 3 > cash Flow > net Change In Cash
-126171637.87
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
0.5555731296813684
Annuals > 3 > ratios > PB
3.290659210651344
Annuals > 3 > ratios > ROE
10.05058733576904
Annuals > 3 > ratios > ROA
4.7537765407098025
Annuals > 3 > ratios > FCF
9889856.549999982
Annuals > 3 > ratios > Piotroski FScore
3
Annuals > 3 > ratios > fcf Percent
0.0015075822533719878
Annuals > 3 > health Score
46
Valuation > metrics > PE
22.7375
Valuation > metrics > PB
2.4473694983341474
Valuation > final Score
100
Valuation > verdict
Fair
Profitability > metrics > ROE
2.1780156858715904
Profitability > metrics > ROA
2.7970653683589095
Profitability > metrics > Net Margin
0.050548822778402044
Profitability > final Score
20
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.7553842736332108
Risk > metrics > Interest Coverage
17.122498153913497
Risk > final Score
88
Risk > verdict
Low
Liquidity > metrics > Current Ratio
3.0218022350406377
Liquidity > metrics > Quick Ratio
2.0915614979946073
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
100
Prev Valuations > 1
100
Prev Valuations > 2
100
Prev Profitabilities > 0
20
Prev Profitabilities > 1
26
Prev Profitabilities > 2
16
Prev Risks > 0
88
Prev Risks > 1
88
Prev Risks > 2
87
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T22:33:48.700Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-09-30
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
0.0658
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-06-30
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
0.2238
Earnings History > 1 > eps Estimate
-
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-03-31
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
0.2233
Earnings History > 2 > eps Estimate
-
Earnings History > 2 > eps Difference
0
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2024-12-31
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
-
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
0.2567
Earnings History > 3 > eps Estimate
-
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-10-29
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
BeforeMarket
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
0.1608
Earnings History > 4 > eps Estimate
-
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-06-30
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
-
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
0.2402
Earnings History > 5 > eps Estimate
-
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-04-25
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
BeforeMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
0.2921
Earnings History > 6 > eps Estimate
-
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2023-12-31
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
-
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
0.2144
Earnings History > 7 > eps Estimate
-
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2023-09-30
Earnings History > 8 > report Date
2023-09-30
Earnings History > 8 > date
2023-09-30
Earnings History > 8 > before After Market
-
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
0.2499
Earnings History > 8 > eps Estimate
-
Earnings History > 8 > eps Difference
0
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2023-06-30
Earnings History > 9 > report Date
2023-06-30
Earnings History > 9 > date
2023-06-30
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
0.241
Earnings History > 9 > eps Estimate
-
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2023-03-31
Earnings History > 10 > report Date
2023-03-31
Earnings History > 10 > date
2023-03-31
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
0.3215
Earnings History > 10 > eps Estimate
-
Earnings History > 10 > eps Difference
0
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2022-12-31
Earnings History > 11 > report Date
2022-12-31
Earnings History > 11 > date
2022-12-31
Earnings History > 11 > before After Market
-
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
0.2471
Earnings History > 11 > eps Estimate
-
Earnings History > 11 > eps Difference
0
Earnings History > 11 > surprise Percent
-
Shandong Xinhua Pharmaceutical Company Limited develops, manufactures, and sells bulk pharmaceuticals, preparations, and chemical products in the People's Republic of China, the Americas, Europe, and internationally. It offers antipyretic and analgesic, cardiovascular and cerebrovascular, anti-infective, and central nervous drugs under the Xinhua brand; and contract manufacturing services for active pharmaceutical ingredients and pharmaceutical intermediates, OTC, and generics. The company also provides ibuprofen bulk pharmaceutical products; and prepared Chinese herbal medicine for decoction, traditional Chinese medicine, chemical bulk drugs, chemical preparations, chemical raw materials, antibiotics, biochemical medicines, anesthetics, anti-psychotic drugs, pharmaceutical precursor chemicals, protein assimilation preparations, peptide hormones, medical toxic drugs, etc. In addition, it offers raw materials and intermediates; internet data services, internet sales, and internet information services for pharmaceuticals and medical devices; veterinary drugs and fodders; bulk pharmaceutical and intermediates; steroid system apis and intermediates; and chemical raw materials. Further, the company produces and sells chemical products; exports and imports goods and technologies; and designs medical projects. Additionally, it engages in the property management, nonresidential real estate leasing, and housing leasing activities; certification and import and export business; electrical equipment engineering; installation and testing of chemical equipment; and manufacture of mechanical and electrical equipment, nonstandard equipment, as well as production and hardware and electrical equipment, and electrical installations equipment and manufacture; and sale of controller switching equipment. The company was founded in 1943 and is based in Zibo, the People's Republic of China.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A(Last Updated 2025-06-30)
Health Score
Price to Earnings Ratio (P/E)
-
High
Low ≥ 50
High ≤ 10
Price to Book Ratio (P/B)
-
High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Shandong Xinhua Pharmaceutical Company Limited
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
0.0658
EPS Estimate
—
EPS Difference
0
Surprise Percent
0%
(Last Updated 2025-06-30)
(Last Updated 2025-06-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-06-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-06-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.